Lung Transplants: What You Need to Know

Lung Transplants: What You Need to Know

Lungs are vital organs. They allow the body to take in oxygen and get rid of carbon dioxide, which is what we call respirations. Sometimes the immune system does not react well to the new lungs after a lung transplant. Watch the video to learn more about this.

Pulmonary Fibrosis: An Invisible Illness

  Meet youtuber Kelly Patricia and watch her talk and explain how it is to live with an invisible illness. “I made this video in honor of all of us who are fighting invisible illnesses. I hope that this can have its own meaning to you. Always remember that…

Pulmonary Fibrosis Treatment with OFEV and Esbriet

https://www.youtube.com/watch?v=DGOc-O6244w Watch Dr. Kevin Huffman, from the Lung Institute, Tampa, Florida, talk about the “FDA fast-tracked Ofev and Esbriet as approved medications for IPF. Together with stem cell therapy, we’re closer to finding a cure for IPF.” Learn more about IPF: http://bit.ly/1QiRmr3…

Idiopathic Pulmonary Fibrosis – “My Father’s Story”

https://www.youtube.com/watch?v=nC9aRdM7xzM Meet Andy. In this touching video, he talks about idiopathic pulmonary fibrosis, the disease that took his father’s life. In a very emotional speech, Andy takes us through his father’s life, from the diagnosis to the doctors appointments and up until his death. “If you or someone you know has…

Last Week’s Hot Topic on Pulmonary Fibrosis

Last week’s hot topic on pulmonary fibrosis was Mechanotherapy Promotes Regeneration of Fibrotic Tissues, Study Shows written by Patricia Inacio. This article is focused on researchers who discovered that mechanotherapy on damaged muscle tissue reduces both fibrotic tissue accumulation and inflammation while helping to increase tissue…

Fibrotic Pathways in IPF May Have a Common Protein and New Treatment Target

A motor protein called myosin II was identified in a recent study to be a driver of fibrosis development — a finding with a notable potential to lead to improved treatments for idiopathic pulmonary fibrosis (IPF). The study by  Cleveland Clinic researchers is titled “Matrix-Driven Myosin II Mediates the Pro-Fibrotic Fibroblast Phenotype,“ and was published in the …

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums